2024. Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report. Dermatology Practical & Conceptual. 14, 4 (Oct. 2024), e2024252. DOI:https://doi.org/10.5826/dpc.1404a252.